[1]
“Evaluation of Inflammatory Markers in Patients with Type 2 Diabetes Mellitus in Derna City, Libya: A Case–Control Study”, DAJAS, vol. 5, no. 2, pp. 161–166, Feb. 2026, doi: 10.71147/427prn62.